Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Foghorn Therapeutics Inc. (NASDAQ: FHTX)
FHTX Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
32.90%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
229.70%
FHTX Stock Analysis
FHTX
PE Ratio:
FHTX
PEG Ratio:
Not Available
FHTX
Forward EPS Growth (12 month):
0.00%
FHTX
PS Ratio:
7.6
FHTX
PSG Ratio:
0.2
FHTX
Forward Revenue Growth (12 month):
40.60%
FHTX Articles
No data was found